An effort expenditure perspective on cancer-related fatigue

Fatigue is the most common, debilitating side effect of cancer and cancer-treatment. Up to 99% of patients report some fatigue during cancer therapy (Servaes et al., 2002) and between 44% and 66% report moderate to severe fatigue (de Jong et al., 2004; Servaes et al., 2002). Although fatigue usually abates after cessation of cancer therapy, it becomes chronic in 22 to 39% of cancer survivors (Goedendorp et al., 2013). Severe fatigue affects quality of life by hampering daily activities and interfering with return to work.

Source: Psychoneuroendocrinology - June 9, 2018 Category: Psychiatry Authors: Tamara E. Lacourt, Elisabeth G. Vichaya, Carmen Escalante, Ellen F. Manzullo, Brandon Gunn, Kenneth R. Hess, Cobi J. Heijnen, Robert Dantzer Source Type: research